Lymphocytosis, lymphadenopathy: benign or malignant?

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Routine immunophenotypic and molecular analyses increasingly identify small clonal lymphoid populations.
• These unexpected clones, sometimes with specific markers like t(14;18), pose diagnostic challenges due to unknown biologic potential and clinical behavior.
• Hematologists/oncologists frequently encounter healthy individuals with lymphadenopathy/lymphocytosis and ambiguous pathology reports.

Purpose of the Study:

• To review challenging clinical scenarios involving small clonal lymphoid populations.
• To provide guidance on the evaluation and management of patients with these findings.
• To discuss the implications of these findings for understanding lymphomagenesis.

Main Methods:

• Review of clinical cases and relevant literature.
• Discussion of diagnostic criteria and management strategies.
• Focus on immunophenotypic and molecular findings.

Main Results:

• Identification of small clonal lymphoid populations is common in routine hematologic evaluations.
• These findings can be difficult to interpret, falling between benign and malignant classifications.
• Study of these lesions offers insights into early stages of lymphomagenesis.

Conclusions:

• Small clonal lymphoid populations require careful evaluation to determine clinical significance.
• Further research into these early lymphoid lesions may inform future preemptive therapeutic strategies.
• Clearer diagnostic and management guidelines are needed for these challenging cases.